What is ORXCF's health score?

ORIX CORP (ORXCF) has a TradeApes health score of 57 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ORXCF's estimated fair value?

Based on our 5-year discounted cash flow model, ORIX CORP's estimated fair value is $3712.29 per share, representing a 9465.3% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ORXCF undervalued or overvalued?

Our model currently rates ORXCF as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ORXCF... Refresh in a moment for the full analysis.

ORIX CORP (ORXCF)

Financials Undervalued medium mixed

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

50 Mixed

Relative Value

95 Strong

Capital Allocation

50 Mixed

Risk

80 Strong

Est. Fair Value $3712.29

DCF Upside +9465.3%

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.